Funding Rounds
Evommune Series A round, September 9, 2021
EvommuneEvommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Summary
Stage: Series A
Raised Amount: $83.00M
Raised Date: 2021-09-09
